Ad is loading...
SNPX
Price
$2.60
Change
+$0.03 (+1.17%)
Updated
Nov 22 closing price
TRAW
Price
$4.46
Change
-$0.05 (-1.11%)
Updated
Nov 22 closing price
Ad is loading...

SNPX vs TRAW

Header iconSNPX vs TRAW Comparison
Open Charts SNPX vs TRAWBanner chart's image
Synaptogenix
Price$2.60
Change+$0.03 (+1.17%)
Volume$4.61K
CapitalizationN/A
Traws Pharma
Price$4.46
Change-$0.05 (-1.11%)
Volume$5.99K
CapitalizationN/A
SNPX vs TRAW Comparison Chart
Loading...
SNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SNPX vs. TRAW commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNPX is a Sell and TRAW is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (SNPX: $2.60 vs. TRAW: $4.46)
Brand notoriety: SNPX and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNPX: 20% vs. TRAW: 41%
Market capitalization -- SNPX: $3.52M vs. TRAW: $13.51M
SNPX [@Biotechnology] is valued at $3.52M. TRAW’s [@Biotechnology] market capitalization is $13.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNPX’s FA Score shows that 2 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • SNPX’s FA Score: 2 green, 3 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, SNPX is a better buy in the long-term than TRAW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNPX’s TA Score shows that 4 TA indicator(s) are bullish while TRAW’s TA Score has 3 bullish TA indicator(s).

  • SNPX’s TA Score: 4 bullish, 5 bearish.
  • TRAW’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SNPX is a better buy in the short-term than TRAW.

Price Growth

SNPX (@Biotechnology) experienced а +8.33% price change this week, while TRAW (@Biotechnology) price change was -10.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

SNPX is expected to report earnings on May 29, 2024.

TRAW is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRAW($13.5M) has a higher market cap than SNPX($3.53M). SNPX YTD gains are higher at: -61.751 vs. TRAW (-76.048). SNPX has higher annual earnings (EBITDA): -6.76M vs. TRAW (-24.08M). SNPX has more cash in the bank: 22.1M vs. TRAW (5.41M). TRAW has higher revenues than SNPX: TRAW (226K) vs SNPX (0).
SNPXTRAWSNPX / TRAW
Capitalization3.53M13.5M26%
EBITDA-6.76M-24.08M28%
Gain YTD-61.751-76.04881%
P/E Ratio2.95N/A-
Revenue0226K-
Total Cash22.1M5.41M409%
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
TRAW: Fundamental Ratings
TRAW
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNPXTRAW
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
SNPX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LWLG2.980.13
+4.75%
Lightwave Logic
HEES58.762.08
+3.67%
H&E Equipment Services
FRES1.310.04
+3.43%
Fresh2 Group Limited
WEX185.383.65
+2.01%
WEX
KRMD3.52-0.06
-1.68%
KORU Medical Systems

SNPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNPX has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if SNPX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPX
1D Price
Change %
SNPX100%
+1.36%
NCNA - SNPX
92%
Closely correlated
-3.15%
RNAC - SNPX
91%
Closely correlated
+13.54%
AGEN - SNPX
91%
Closely correlated
+16.78%
ALLR - SNPX
87%
Closely correlated
+0.79%
NRXP - SNPX
84%
Closely correlated
+2.44%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with MDGL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-1.01%
MDGL - TRAW
39%
Loosely correlated
+5.53%
CYTK - TRAW
36%
Loosely correlated
+3.00%
ORMP - TRAW
34%
Loosely correlated
+1.30%
SNPX - TRAW
32%
Poorly correlated
+1.36%
AXON - TRAW
32%
Poorly correlated
+0.90%
More